YBX1 and myeloid leukemia: YB1 can interact with insulin-like growth factor receptor 2 messenger RNA binding protein (IGF2BP) and stabilize N6-methyladenosine (m6A) modified RNA such as MYC and BCL2 mRNA, supporting the survival of myeloid leukemia cells, although YB1 does not appear to affect normal hematopoietic function (51).